WP4: Delphi Process

Through this Delphi study, the following aspects will be defined: 

• characterisation of candidate patients for discussion about ATT deprescribing
• healthcare team roles in ATT decision-making
• specific information and communication requirements for patients when making deprescribing decisions
• SDST content priorities; and optimal outcomes for the planned clinical trial.